Please use this identifier to cite or link to this item:
Authors: Saurin, Sabrina
Meineck, Myriam
Erkel, Gerhard
Opatz, Till
Weinmann-Menke, Julia
Pautz, Andrea
Title: Drug candidates for autoimmune diseases
Online publication date: 13-Jan-2023
Year of first publication: 2022
Language: english
Abstract: Most of the immunosuppressive drugs used in the clinic to prevent organ rejection or to treat autoimmune disorders were originally isolated from fungi or bacteria. Therefore, in addition to plants, these are valuable sources for identification of new potent drugs. Many side effects of established drugs limit their usage and make the identification of new immunosuppressants necessary. In this review, we present a comprehensive overview of natural products with potent anti-inflammatory activities that have been tested successfully in different models of chronic inflammatory autoimmune diseases. Some of these candidates already have passed first clinical trials. The anti-inflammatory potency of these natural products was often comparable to those of established drugs, and they could be used at least in addition to standard therapy to reduce their dose to minimize unwanted side effects. A frequent mode of action is the inhibition of classical inflammatory signaling pathways, such as NF-κB, in combination with downregulation of oxidative stress. A drawback for the therapeutic use of those natural products is their moderate bioavailability, which can be optimized by chemical modifications and, in addition, further safety studies are necessary. Altogether, very interesting candidate compounds exist which have the potential to serve as starting points for the development of new immunosuppressive drugs.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
Version: Published version
Publication type: Zeitschriftenaufsatz
Document type specification: Scientific article
License: CC BY
Information on rights of use:
Journal: Pharmaceuticals
Pages or article number: 503
Publisher: MDPI
Publisher place: Basel
Issue date: 2022
ISSN: 1424-8247
Publisher DOI: 10.3390/ph15050503
Appears in collections:DFG-491381577-G

Files in This Item:
  File Description SizeFormat
drug_candidates_for_autoimmun-20230112132020289.pdf3.69 MBAdobe PDFView/Open